Cortes discussed the evolution of chronic myeloid leukemia treatment and emerging strategies aimed at improving outcomes and quality of life. Dr. Jorge E. Cortes sat down with CURE to discuss the ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

Neuroendocrine tumors originate from neuroendocrine cells, often presenting as slower-growing compared to other cancers like ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Today, HRT is recognized as essential. Key takeaways: It helps with more than hot flashes, supporting bone, heart and brain ...

The FDA's fast track designation aims to expedite ITM-94's development for diagnosing clear cell renal cell carcinoma. The ...

ACRO Accreditation is the only U.S. radiation oncology accrediting body to acieve ISO 9001:2015 Certification.

The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan ...

AI integration in cancer care aids patients in navigating complex treatment decisions and identifying relevant clinical ...

A nurse navigator provided essential support and guidance throughout the breast cancer journey, from diagnosis to treatment ...